目的建立C57BL/6j小鼠人神经母细胞瘤移植瘤模型。方法取对数生长期SK—N—SH细胞1×10^7个ml,分别接种3d、7d、3周、4周、5周、6周、7周C57BIM6j系小鼠及6周BALB/C系裸鼠,观察小鼠成瘤率、相对肿瘤体积(RTV)、相对肿瘤增长速率(K)、相对肿瘤倍增时间(Td)、宿主存活时间及移植瘤病理学情况。结果C57BL/6j各年龄段及BALB/C持续成瘤率分别为:100%、100%、90%、70%、60%、0%、0%、100%。3周龄C57BL/6i与BALB/C比较RTV、K、.rd及存活时间均差异无统计学意义(P〉0.05)。结论在C57BIM6j小鼠体内成功建立人类异种移植瘤模型,3周龄为最适宜接种时间点。
Objective To investigate the feasibility of human neuroblastoma xenograft model in C57BL/6j mice. Methods Three-day, 7-day, 3-week, 4-week, 5-week, 6-week and 7-week age C57BL/6j and 6-week age BALB/C nude mice were subcutaneously inoculated with 1×10^7 cell/ml SK-N- SH cells in logarithmic phase, respectively. The tumor generation rate, relative tumor volume (RTV) , relative growth rate (K) , relative doubling time (Td), survival time and pathological changes were tested. Results The continuing tumor generation rate of C57BL/6j mice and BALB/C nude mice was 100% ( 10/ 10) at the 3rd day, 100% (10//10) at the 7th day, 90% (9/10) at the 3rd week and 70% (7/10) at the 4th week, 60% (6/10) at the 5th week, 0% (0/10) at the 6th week, 0% (0/10) at the 7th week, and 100% (10/10) at the 6th week, respectively. There was no significant difference in RTV, K, Td, and survival time (P 〉 0. 05 ) between 3-week age C57BL/6j mice and BALB/C nude mice. Conclusion Human neuroblastoma xenograft models were successfully established the in C57BL/6j mice, and 3-week age was the most appropriate opportunity of vaccination.